{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:56:42Z","timestamp":1790729802669,"version":"4.1.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R35-CA197459"],"award-info":[{"award-number":["R35-CA197459"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["P01-CA120964"],"award-info":[{"award-number":["P01-CA120964"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32-DK128781"],"award-info":[{"award-number":["T32-DK128781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["F31-DK128873"],"award-info":[{"award-number":["F31-DK128873"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["T32-DK128781"],"award-info":[{"award-number":["T32-DK128781"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77216-6","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:46:06Z","timestamp":1788187566000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dietary protein governs the role of insulin signaling in the postprandial regulation of hepatic mTORC1"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-5533","authenticated-orcid":false,"given":"Krystle C.","family":"Kalafut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4913-0327","authenticated-orcid":false,"given":"Yann","family":"Cormerais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madi Y.","family":"Ciss\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C.","family":"Lapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Inouye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2906-1897","authenticated-orcid":false,"given":"G\u00f6khan S.","family":"Hotam\u0131\u015fl\u0131gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3895-5956","authenticated-orcid":false,"given":"Brendan D.","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"77216_CR1","doi-asserted-by":"publisher","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","volume":"27","author":"E Trefts","year":"2017","unstructured":"Trefts, E., Gannon, M. & Wasserman, D. H. The liver. Curr. Biol. 27, R1147\u2013R1151 (2017).","journal-title":"Curr. Biol."},{"key":"77216_CR2","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1146\/annurev-pathmechdis-042624-091820","volume":"21","author":"TM Yasaka","year":"2026","unstructured":"Yasaka, T. M., Kim, C. K., Meadows, V. & Monga, S. P. Zonation, zonation, zonation: the real estate of the liver. Annu. Rev. Pathol. 21, 185\u2013212 (2026).","journal-title":"Annu. Rev. Pathol."},{"key":"77216_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","volume":"28","author":"PM Titchenell","year":"2017","unstructured":"Titchenell, P. M., Lazar, M. A. & Birnbaum, M. J. Unraveling the regulation of hepatic metabolism by insulin. Trends Endocrinol. Metab. 28, 497\u2013505 (2017).","journal-title":"Trends Endocrinol. Metab."},{"key":"77216_CR4","doi-asserted-by":"publisher","first-page":"18769","DOI":"10.1074\/jbc.M112.365544","volume":"287","author":"EJ Bae","year":"2012","unstructured":"Bae, E. J. et al. Liver-specific p70 S6 kinase depletion protects against hepatic steatosis and systemic insulin resistance. J. Biol. Chem. 287, 18769\u201318780 (2012).","journal-title":"J. Biol. Chem."},{"key":"77216_CR5","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41392-022-01073-0","volume":"7","author":"M Li","year":"2022","unstructured":"Li, M. et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct. Target. Ther. 7, 216 (2022).","journal-title":"Signal Transduct. Target. Ther."},{"key":"77216_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s42255-019-0038-7","volume":"1","author":"AJ Valvezan","year":"2019","unstructured":"Valvezan, A. J. & Manning, B. D. Molecular logic of mTORC1 signalling as a metabolic rheostat. Nat. Metab. 1, 321\u2013333 (2019).","journal-title":"Nat. Metab."},{"key":"77216_CR7","first-page":"109","volume":"39","author":"L He","year":"2025","unstructured":"He, L., Cho, S. & Blenis, J. mTORC1, the maestro of cell metabolism and growth. Genes Dev. 39, 109\u2013131 (2025).","journal-title":"Genes Dev."},{"key":"77216_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/s41580-023-00641-8","volume":"24","author":"C Goul","year":"2023","unstructured":"Goul, C., Peruzzo, R. & Zoncu, R. The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease. Nat. Rev. Mol. Cell Biol. 24, 857\u2013875 (2023).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"77216_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.cell.2017.02.004","volume":"168","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell 168, 960\u2013976 (2017).","journal-title":"Cell"},{"key":"77216_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cmet.2011.06.002","volume":"14","author":"JL Yecies","year":"2011","unstructured":"Yecies, J. L. et al. Akt stimulates hepatic SREBP1c and lipogenesis through parallel mTORC1-dependent and independent pathways. Cell Metab. 14, 21\u201332 (2011).","journal-title":"Cell Metab."},{"key":"77216_CR11","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/nature09584","volume":"468","author":"S Sengupta","year":"2010","unstructured":"Sengupta, S., Peterson, T. R., Laplante, M., Oh, S. & Sabatini, D. M. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468, 1100\u20131104 (2010).","journal-title":"Nature"},{"key":"77216_CR12","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/nature02866","volume":"431","author":"SH Um","year":"2004","unstructured":"Um, S. H. et al. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431, 200\u2013205 (2004).","journal-title":"Nature"},{"key":"77216_CR13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1210\/en.2004-0921","volume":"146","author":"L Khamzina","year":"2005","unstructured":"Khamzina, L., Veilleux, A., Bergeron, S. & Marette, A. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance. Endocrinology 146, 1473\u20131481 (2005).","journal-title":"Endocrinology"},{"key":"77216_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1042\/bj3440427","volume":"344","author":"BT Nave","year":"1999","unstructured":"Nave, B. T., Ouwens, M., Withers, D. J., Alessi, D. R. & Shepherd, P. R. Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochem. J. 344, 427\u2013431 (1999).","journal-title":"Biochem. J."},{"key":"77216_CR15","first-page":"3504","volume":"60","author":"A Sekulic","year":"2000","unstructured":"Sekulic, A. et al. A direct linkage between the phosphoinositide 3-kinase-AKT signaling pathway and the mammalian target of rapamycin in mitogen-stimulated and transformed cells. Cancer Res. 60, 3504\u20133513 (2000).","journal-title":"Cancer Res."},{"key":"77216_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ncb1547","volume":"9","author":"E Vander Haar","year":"2007","unstructured":"Vander Haar, E., Lee, S. I., Bandhakavi, S., Griffin, T. J. & Kim, D. H. Insulin signalling to mTOR mediated by the Akt\/PKB substrate PRAS40. Nat. Cell Biol. 9, 316\u2013323 (2007).","journal-title":"Nat. Cell Biol."},{"key":"77216_CR17","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.molcel.2007.03.003","volume":"25","author":"Y Sancak","year":"2007","unstructured":"Sancak, Y. et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903\u2013915 (2007).","journal-title":"Mol. Cell"},{"key":"77216_CR18","doi-asserted-by":"publisher","first-page":"32081","DOI":"10.1074\/jbc.M502876200","volume":"280","author":"A Hahn-Windgassen","year":"2005","unstructured":"Hahn-Windgassen, A. et al. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J. Biol. Chem. 280, 32081\u201332089 (2005).","journal-title":"J. Biol. Chem."},{"key":"77216_CR19","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.1074\/jbc.M506850200","volume":"281","author":"S Horman","year":"2006","unstructured":"Horman, S. et al. Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase alpha-subunits in heart via hierarchical phosphorylation of Ser485\/491. J. Biol. Chem. 281, 5335\u20135340 (2006).","journal-title":"J. Biol. Chem."},{"key":"77216_CR20","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning, B. D., Tee, A. R., Logsdon, M. N., Blenis, J. & Cantley, L. C. Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol. Cell 10, 151\u2013162 (2002).","journal-title":"Mol. Cell"},{"key":"77216_CR21","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki, K., Li, Y., Zhu, T., Wu, J. & Guan, K. L. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell Biol. 4, 648\u2013657 (2002).","journal-title":"Nat. Cell Biol."},{"key":"77216_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adw4165","volume":"18","author":"K Wang","year":"2025","unstructured":"Wang, K., Lockwood, S. E. & Manning, B. D. Evolution of growth factor signaling to the TSC complex to regulate mTORC1. Sci. Signal. 18, eadw4165 (2025).","journal-title":"Sci. Signal."},{"key":"77216_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Li, Y., Xu, T. & Guan, K. L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 17, 1829\u20131834 (2003).","journal-title":"Genes Dev."},{"key":"77216_CR24","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. & Blenis, J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 13, 1259\u20131268 (2003).","journal-title":"Curr. Biol."},{"key":"77216_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20522-4","volume":"12","author":"H Yang","year":"2021","unstructured":"Yang, H. et al. Structural insights into TSC complex assembly and GAP activity on Rheb. Nat. Commun. 12, 339 (2021).","journal-title":"Nat. Commun."},{"key":"77216_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.cell.2013.11.049","volume":"156","author":"S Menon","year":"2014","unstructured":"Menon, S. et al. Spatial control of the TSC complex integrates insulin and nutrient regulation of mTORC1 at the lysosome. Cell 156, 771\u2013785 (2014).","journal-title":"Cell"},{"key":"77216_CR27","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature25023","volume":"552","author":"H Yang","year":"2017","unstructured":"Yang, H. et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature 552, 368\u2013373 (2017).","journal-title":"Nature"},{"key":"77216_CR28","doi-asserted-by":"publisher","first-page":"e6189","DOI":"10.1371\/journal.pone.0006189","volume":"4","author":"HH Zhang","year":"2009","unstructured":"Zhang, H. H. et al. Insulin stimulates adipogenesis through the Akt-TSC2-mTORC1 pathway. PLoS ONE 4, e6189 (2009).","journal-title":"PLoS ONE"},{"key":"77216_CR29","doi-asserted-by":"publisher","first-page":"e18075","DOI":"10.1371\/journal.pone.0018075","volume":"6","author":"HL Kenerson","year":"2011","unstructured":"Kenerson, H. L., Yeh, M. M. & Yeung, R. S. Tuberous sclerosis complex-1 deficiency attenuates diet-induced hepatic lipid accumulation. PLoS ONE 6, e18075 (2011).","journal-title":"PLoS ONE"},{"key":"77216_CR30","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2016.12.009","volume":"25","author":"JJ Howell","year":"2017","unstructured":"Howell, J. J. et al. Metformin inhibits hepatic mTORC1 signaling via dose-dependent mechanisms involving AMPK and the TSC complex. Cell Metab. 25, 463\u2013471 (2017).","journal-title":"Cell Metab."},{"key":"77216_CR31","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1126\/science.292.5522.1728","volume":"292","author":"H Cho","year":"2001","unstructured":"Cho, H. et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292, 1728\u20131731 (2001).","journal-title":"Science"},{"key":"77216_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.cmet.2009.10.004","volume":"10","author":"KF Leavens","year":"2009","unstructured":"Leavens, K. F., Easton, R. M., Shulman, G. I., Previs, S. F. & Birnbaum, M. J. Akt2 is required for hepatic lipid accumulation in models of insulin resistance. Cell Metab. 10, 405\u2013418 (2009).","journal-title":"Cell Metab."},{"key":"77216_CR33","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2011.09.001","volume":"14","author":"M Wan","year":"2011","unstructured":"Wan, M. et al. Postprandial hepatic lipid metabolism requires signaling through Akt2 independent of the transcription factors FoxA2, FoxO1, and SREBP1c. Cell Metab. 14, 516\u2013527 (2011).","journal-title":"Cell Metab."},{"key":"77216_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nm.2686","volume":"18","author":"M Lu","year":"2012","unstructured":"Lu, M. et al. Insulin regulates liver metabolism in vivo in the absence of hepatic Akt and Foxo1. Nat. Med. 18, 388\u2013395 (2012).","journal-title":"Nat. Med."},{"key":"77216_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8078","volume":"6","author":"PM Titchenell","year":"2015","unstructured":"Titchenell, P. M., Chu, Q., Monks, B. R. & Birnbaum, M. J. Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo. Nat. Commun. 6, 7078 (2015).","journal-title":"Nat. Commun."},{"key":"77216_CR36","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1016\/j.cmet.2016.04.022","volume":"23","author":"PM Titchenell","year":"2016","unstructured":"Titchenell, P. M. et al. Direct hepatocyte insulin signaling is required for lipogenesis but is dispensable for the suppression of glucose production. Cell Metab. 23, 1154\u20131166 (2016).","journal-title":"Cell Metab."},{"key":"77216_CR37","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.devcel.2006.10.007","volume":"11","author":"DA Guertin","year":"2006","unstructured":"Guertin, D. A. et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev. Cell 11, 859\u2013871 (2006).","journal-title":"Dev. Cell"},{"key":"77216_CR38","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.cell.2011.06.034","volume":"146","author":"TR Peterson","year":"2011","unstructured":"Peterson, T. R. et al. mTOR complex 1 regulates lipin 1 localization to control the SREBP pathway. Cell 146, 408\u2013420 (2011).","journal-title":"Cell"},{"key":"77216_CR39","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501 (2008).","journal-title":"Science"},{"key":"77216_CR40","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.tibs.2026.02.009","volume":"51","author":"S Yang","year":"2026","unstructured":"Yang, S., Bian, T. & Zoncu, R. Molecular and structural mechanisms of nutrient sensing in the mTORC1 pathway. Trends Biochem. Sci. 51, 457\u2013473 (2026).","journal-title":"Trends Biochem. Sci."},{"key":"77216_CR41","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","volume":"141","author":"Y Sancak","year":"2010","unstructured":"Sancak, Y. et al. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141, 290\u2013303 (2010).","journal-title":"Cell"},{"key":"77216_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23857-8","volume":"12","author":"C de la Calle Arregui","year":"2021","unstructured":"de la Calle Arregui, C. et al. Limited survival and impaired hepatic fasting metabolism in mice with constitutive Rag GTPase signaling. Nat. Commun. 12, 3660 (2021).","journal-title":"Nat. Commun."},{"key":"77216_CR43","doi-asserted-by":"publisher","first-page":"E719","DOI":"10.1152\/ajpendo.00253.2007","volume":"294","author":"Y Koketsu","year":"2008","unstructured":"Koketsu, Y. et al. Hepatic overexpression of a dominant negative form of raptor enhances Akt phosphorylation and restores insulin sensitivity in K\/KAy mice. Am. J. Physiol. Endocrinol. Metab. 294, E719\u2013E725 (2008).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"77216_CR44","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf8271","volume":"376","author":"BS Gosis","year":"2022","unstructured":"Gosis, B. S. et al. Inhibition of nonalcoholic fatty liver disease in mice by selective inhibition of mTORC1. Science 376, eabf8271 (2022).","journal-title":"Science"},{"key":"77216_CR45","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1126\/science.1199484","volume":"332","author":"Y Yu","year":"2011","unstructured":"Yu, Y. et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322\u20131326 (2011).","journal-title":"Science"},{"key":"77216_CR46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.1199498","volume":"332","author":"PP Hsu","year":"2011","unstructured":"Hsu, P. P. et al. The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317\u20131322 (2011).","journal-title":"Science"},{"key":"77216_CR47","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1007\/s00125-012-2644-8","volume":"55","author":"KD Copps","year":"2012","unstructured":"Copps, K. D. & White, M. F. Regulation of insulin sensitivity by serine\/threonine phosphorylation of insulin receptor substrate proteins IRS1 and IRS2. Diabetologia 55, 2565\u20132582 (2012).","journal-title":"Diabetologia"},{"key":"77216_CR48","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1128\/MCB.01254-05","volume":"26","author":"OJ Shah","year":"2006","unstructured":"Shah, O. J. & Hunter, T. Turnover of the active fraction of IRS1 involves raptor-mTOR- and S6K1-dependent serine phosphorylation in cell culture models of tuberous sclerosis. Mol. Cell. Biol. 26, 6425\u20136434 (2006).","journal-title":"Mol. Cell. Biol."},{"key":"77216_CR49","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1128\/MCB.00735-09","volume":"29","author":"CC Dibble","year":"2009","unstructured":"Dibble, C. C., Asara, J. M. & Manning, B. D. Characterization of Rictor phosphorylation sites reveals direct regulation of mTOR complex 2 by S6K1. Mol. Cell. Biol. 29, 5657\u20135670 (2009).","journal-title":"Mol. Cell. Biol."},{"key":"77216_CR50","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.00601-09","volume":"30","author":"LA Julien","year":"2010","unstructured":"Julien, L. A., Carriere, A., Moreau, J. & Roux, P. P. mTORC1-activated S6K1 phosphorylates Rictor on threonine 1135 and regulates mTORC2 signaling. Mol. Cell. Biol. 30, 908\u2013921 (2010).","journal-title":"Mol. Cell. Biol."},{"key":"77216_CR51","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1172\/JCI96036","volume":"127","author":"WJ Quinn","year":"2017","unstructured":"Quinn, W. J. et al. mTORC1 stimulates phosphatidylcholine synthesis to promote triglyceride secretion. J. Clin. Investig. 127, 4207\u20134215 (2017).","journal-title":"J. Clin. Investig."},{"key":"77216_CR52","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1016\/j.devcel.2025.05.008","volume":"60","author":"Y Cormerais","year":"2025","unstructured":"Cormerais, Y. et al. AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth. Dev. Cell 60, 2544\u20132557 (2025).","journal-title":"Dev. Cell"},{"key":"77216_CR53","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.immuni.2006.04.005","volume":"24","author":"Y Sasaki","year":"2006","unstructured":"Sasaki, Y. et al. Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation. Immunity 24, 729\u2013739 (2006).","journal-title":"Immunity"},{"key":"77216_CR54","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.molcel.2012.06.009","volume":"47","author":"CC Dibble","year":"2012","unstructured":"Dibble, C. C. et al. TBC1d7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol. Cell 47, 535\u2013546 (2012).","journal-title":"Mol. Cell"},{"key":"77216_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110824","volume":"39","author":"S Schrotter","year":"2022","unstructured":"Schrotter, S. et al. The non-essential TSC complex component TBC1d7 restricts tissue mTORC1 signaling and brain and neuron growth. Cell Rep. 39, 110824 (2022).","journal-title":"Cell Rep."},{"key":"77216_CR56","doi-asserted-by":"publisher","first-page":"4385","DOI":"10.1016\/j.molcel.2024.10.008","volume":"84","author":"A Acharya","year":"2024","unstructured":"Acharya, A. & Demetriades, C. mTORC1 activity licenses its own release from the lysosomal surface. Mol. Cell 84, 4385\u20134400.e4387 (2024).","journal-title":"Mol. Cell"},{"key":"77216_CR57","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s41586-022-05652-7","volume":"614","author":"Z Cui","year":"2023","unstructured":"Cui, Z. et al. Structure of the lysosomal mTORC1-TFEB-Rag-Ragulator megacomplex. Nature 614, 572\u2013579 (2023).","journal-title":"Nature"},{"key":"77216_CR58","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-2444-0","volume":"585","author":"G Napolitano","year":"2020","unstructured":"Napolitano, G. et al. A substrate-specific mTORC1 pathway underlies Birt-Hogg-Dube syndrome. Nature 585, 597\u2013602 (2020).","journal-title":"Nature"},{"key":"77216_CR59","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1038\/emboj.2012.32","volume":"31","author":"C Settembre","year":"2012","unstructured":"Settembre, C. et al. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J. 31, 1095\u20131108 (2012).","journal-title":"EMBO J."},{"key":"77216_CR60","doi-asserted-by":"crossref","unstructured":"Roczniak-Ferguson, A. et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5, ra42 (2012).","DOI":"10.1126\/scisignal.2002790"},{"key":"77216_CR61","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.cmet.2017.07.001","volume":"26","author":"RL Wolfson","year":"2017","unstructured":"Wolfson, R. L. & Sabatini, D. M. The dawn of the age of amino acid sensors for the mTORC1 pathway. Cell Metab. 26, 301\u2013309 (2017).","journal-title":"Cell Metab."},{"key":"77216_CR62","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1210\/jcem-27-11-1600","volume":"27","author":"SS Fajans","year":"1967","unstructured":"Fajans, S. S. et al. A difference in mechanism by which leucine and other amino acids induce insulin release. J. Clin. Endocrinol. Metab. 27, 1600\u20131606 (1967).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"77216_CR63","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1172\/JCI107822","volume":"54","author":"AS Pagliara","year":"1974","unstructured":"Pagliara, A. S., Stillings, S. N., Hover, B., Martin, D. M. & Matschinsky, F. M. Glucose modulation of amino acid-induced glucagon and insulin release in the isolated perfused rat pancreas. J. Clin. Investig. 54, 819\u2013832 (1974).","journal-title":"J. Clin. Investig."},{"key":"77216_CR64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41574-025-01100-4","volume":"21","author":"PJ White","year":"2025","unstructured":"White, P. J., Wewer Albrechtsen, N. J. & Campbell, J. E. Islet hormones at the intersection of glucose and amino acid metabolism. Nat. Rev. Endocrinol. 21, 397\u2013412 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"77216_CR65","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.cell.2017.03.023","volume":"169","author":"JR Cantor","year":"2017","unstructured":"Cantor, J. R. et al. Physiologic medium rewires cellular metabolism and reveals uric acid as an endogenous inhibitor of UMP synthase. Cell 169, 258\u2013272.e217 (2017).","journal-title":"Cell"},{"key":"77216_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111187","volume":"40","author":"MR MacArthur","year":"2022","unstructured":"MacArthur, M. R. et al. Multiomics assessment of dietary protein titration reveals altered hepatic glucose utilization. Cell Rep. 40, 111187 (2022).","journal-title":"Cell Rep."},{"key":"77216_CR67","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/j.celrep.2014.07.018","volume":"8","author":"E Harputlugil","year":"2014","unstructured":"Harputlugil, E. et al. The TSC complex is required for the benefits of dietary protein restriction on stress resistance in vivo. Cell Rep. 8, 1160\u20131170 (2014).","journal-title":"Cell Rep."},{"key":"77216_CR68","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.cmet.2013.03.015","volume":"17","author":"P Castets","year":"2013","unstructured":"Castets, P. et al. Sustained activation of mTORC1 in skeletal muscle inhibits constitutive and starvation-induced autophagy and causes a severe, late-onset myopathy. Cell Metab. 17, 731\u2013744 (2013).","journal-title":"Cell Metab."},{"key":"77216_CR69","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cmet.2008.10.002","volume":"8","author":"CF Bentzinger","year":"2008","unstructured":"Bentzinger, C. F. et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 8, 411\u2013424 (2008).","journal-title":"Cell Metab."},{"key":"77216_CR70","doi-asserted-by":"crossref","unstructured":"Guridi, M. et al. Activation of mTORC1 in skeletal muscle regulates whole-body metabolism through FGF21. Sci. Signal. 8, ra113 (2015).","DOI":"10.1126\/scisignal.aab3715"},{"key":"77216_CR71","doi-asserted-by":"publisher","first-page":"42628","DOI":"10.1074\/jbc.M405173200","volume":"279","author":"I Mothe-Satney","year":"2004","unstructured":"Mothe-Satney, I., Gautier, N., Hinault, C., Lawrence, J. C. Jr. & Van Obberghen, E. In rat hepatocytes glucagon increases mammalian target of rapamycin phosphorylation on serine 2448 but antagonizes the phosphorylation of its downstream targets induced by insulin and amino acids. J. Biol. Chem. 279, 42628\u201342637 (2004).","journal-title":"J. Biol. Chem."},{"key":"77216_CR72","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.43038","volume":"8","author":"JL Jewell","year":"2019","unstructured":"Jewell, J. L. et al. GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor. Elife 8, e43038 (2019).","journal-title":"Elife"},{"key":"77216_CR73","doi-asserted-by":"publisher","first-page":"54103","DOI":"10.1074\/jbc.M410755200","volume":"279","author":"SR Kimball","year":"2004","unstructured":"Kimball, S. R., Siegfried, B. A. & Jefferson, L. S. Glucagon represses signaling through the mammalian target of rapamycin in rat liver by activating AMP-activated protein kinase. J. Biol. Chem. 279, 54103\u201354109 (2004).","journal-title":"J. Biol. Chem."},{"key":"77216_CR74","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1016\/j.cellsig.2011.06.025","volume":"23","author":"J Xie","year":"2011","unstructured":"Xie, J. et al. cAMP inhibits mammalian target of rapamycin complex-1 and -2 (mTORC1 and 2) by promoting complex dissociation and inhibiting mTOR kinase activity. Cell Signal. 23, 1927\u20131935 (2011).","journal-title":"Cell Signal."},{"key":"77216_CR75","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.2337\/db11-1605","volume":"62","author":"C Longuet","year":"2013","unstructured":"Longuet, C. et al. Liver-specific disruption of the murine glucagon receptor produces alpha-cell hyperplasia: evidence for a circulating alpha-cell growth factor. Diabetes 62, 1196\u20131205 (2013).","journal-title":"Diabetes"},{"key":"77216_CR76","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/emmm.201303183","volume":"6","author":"M Volkers","year":"2014","unstructured":"Volkers, M. et al. PRAS40 prevents development of diabetic cardiomyopathy and improves hepatic insulin sensitivity in obesity. EMBO Mol. Med. 6, 57\u201365 (2014).","journal-title":"EMBO Mol. Med."},{"key":"77216_CR77","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S0092-8674(03)00929-2","volume":"115","author":"K Inoki","year":"2003","unstructured":"Inoki, K., Zhu, T. & Guan, K. L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 115, 577\u2013590 (2003).","journal-title":"Cell"},{"key":"77216_CR78","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214\u2013226 (2008).","journal-title":"Mol. Cell"},{"key":"77216_CR79","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/s41422-020-00456-8","volume":"31","author":"M Li","year":"2021","unstructured":"Li, M. et al. Aldolase is a sensor for both low and high glucose, linking to AMPK and mTORC1. Cell Res. 31, 478\u2013481 (2021).","journal-title":"Cell Res."},{"key":"77216_CR80","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s42255-022-00732-4","volume":"5","author":"X Dai","year":"2023","unstructured":"Dai, X. et al. AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation. Nat. Metab. 5, 265\u2013276 (2023).","journal-title":"Nat. Metab."},{"key":"77216_CR81","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nature21423","volume":"543","author":"RL Wolfson","year":"2017","unstructured":"Wolfson, R. L. et al. KICSTOR recruits GATOR1 to the lysosome and is necessary for nutrients to regulate mTORC1. Nature 543, 438\u2013442 (2017).","journal-title":"Nature"},{"key":"77216_CR82","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s42255-020-0250-5","volume":"2","author":"JM Orozco","year":"2020","unstructured":"Orozco, J. M. et al. Dihydroxyacetone phosphate signals glucose availability to mTORC1. Nat. Metab. 2, 893\u2013901 (2020).","journal-title":"Nat. Metab."},{"key":"77216_CR83","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1016\/j.cmet.2012.05.002","volume":"15","author":"JT Haas","year":"2012","unstructured":"Haas, J. T. et al. Hepatic insulin signaling is required for obesity-dependent expression of SREBP-1c mRNA but not for feeding-dependent expression. Cell Metab. 15, 873\u2013884 (2012).","journal-title":"Cell Metab."},{"key":"77216_CR84","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1126\/science.abi9547","volume":"377","author":"AL Cangelosi","year":"2022","unstructured":"Cangelosi, A. L. et al. Zonated leucine sensing by Sestrin-mTORC1 in the liver controls the response to dietary leucine. Science 377, 47\u201356 (2022).","journal-title":"Science"},{"key":"77216_CR85","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nature11745","volume":"493","author":"A Efeyan","year":"2013","unstructured":"Efeyan, A. et al. Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival. Nature 493, 679\u2013683 (2013).","journal-title":"Nature"},{"key":"77216_CR86","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.3945\/jn.115.215491","volume":"145","author":"SR Kimball","year":"2015","unstructured":"Kimball, S. R., Ravi, S., Gordon, B. S., Dennis, M. D. & Jefferson, L. S. Amino acid-induced activation of mTORC1 in rat liver is attenuated by short-term consumption of a high-fat diet. J. Nutr. 145, 2496\u20132502 (2015).","journal-title":"J. Nutr."},{"key":"77216_CR87","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.cell.2018.10.015","volume":"175","author":"C Brandt","year":"2018","unstructured":"Brandt, C. et al. Food perception primes hepatic ER homeostasis via melanocortin-dependent control of mTOR activation. Cell 175, 1321\u20131335.e1320 (2018).","journal-title":"Cell"},{"key":"77216_CR88","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1074\/jbc.M117.782557","volume":"293","author":"Y Hu","year":"2018","unstructured":"Hu, Y. et al. Fructose and glucose can regulate mammalian target of rapamycin complex 1 and lipogenic gene expression via distinct pathways. J. Biol. Chem. 293, 2006\u20132014 (2018).","journal-title":"J. Biol. Chem."},{"key":"77216_CR89","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"77216_CR90","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311\u2013326 (2009).","journal-title":"Cell Metab."},{"key":"77216_CR91","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","volume":"15","author":"CB Newgard","year":"2012","unstructured":"Newgard, C. B. Interplay between lipids and branched-chain amino acids in development of insulin resistance. Cell Metab. 15, 606\u2013614 (2012).","journal-title":"Cell Metab."},{"key":"77216_CR92","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nm.4057","volume":"22","author":"C Jang","year":"2016","unstructured":"Jang, C. et al. A branched-chain amino acid metabolite drives vascular fatty acid transport and causes insulin resistance. Nat. Med. 22, 421\u2013426 (2016).","journal-title":"Nat. Med."},{"key":"77216_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46032-1","volume":"15","author":"AB Plata-Gomez","year":"2024","unstructured":"Plata-Gomez, A. B. et al. Hepatic nutrient and hormone signaling to mTORC1 instructs the postnatal metabolic zonation of the liver. Nat. Commun. 15, 1878 (2024).","journal-title":"Nat. Commun."},{"key":"77216_CR94","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41575-019-0134-x","volume":"16","author":"S Ben-Moshe","year":"2019","unstructured":"Ben-Moshe, S. & Itzkovitz, S. Spatial heterogeneity in the mammalian liver. Nat. Rev. Gastroenterol. Hepatol. 16, 395\u2013410 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"77216_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101080","volume":"42","author":"M Winther-Sorensen","year":"2020","unstructured":"Winther-Sorensen, M. et al. Glucagon acutely regulates hepatic amino acid catabolism and the effect may be disturbed by steatosis. Mol. Metab. 42, 101080 (2020).","journal-title":"Mol. Metab."},{"key":"77216_CR96","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1210\/en.2017-00521","volume":"159","author":"I Goldstein","year":"2018","unstructured":"Goldstein, I. & Hager, G. L. The three Ds of transcription activation by glucagon: direct, delayed, and dynamic. Endocrinology 159, 206\u2013216 (2018).","journal-title":"Endocrinology"},{"key":"77216_CR97","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-12-281","volume":"12","author":"J Yang","year":"2011","unstructured":"Yang, J. et al. Polyomic profiling reveals significant hepatic metabolic alterations in glucagon-receptor (GCGR) knockout mice: implications on anti-glucagon therapies for diabetes. BMC Genom. 12, 281 (2011).","journal-title":"BMC Genom."},{"key":"77216_CR98","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.cmet.2008.09.008","volume":"8","author":"C Longuet","year":"2008","unstructured":"Longuet, C. et al. The glucagon receptor is required for the adaptive metabolic response to fasting. Cell Metab. 8, 359\u2013371 (2008).","journal-title":"Cell Metab."},{"key":"77216_CR99","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1073\/pnas.0237106100","volume":"100","author":"RW Gelling","year":"2003","unstructured":"Gelling, R. W. et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc. Natl. Acad. Sci. USA 100, 1438\u20131443 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77216_CR100","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1530\/JOE-19-0201","volume":"243","author":"JH Stern","year":"2019","unstructured":"Stern, J. H. et al. Obesity dysregulates fasting-induced changes in glucagon secretion. J. Endocrinol. 243, 149\u2013160 (2019).","journal-title":"J. Endocrinol."},{"key":"77216_CR101","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/jn\/123.2.269","volume":"123","author":"N Orentreich","year":"1993","unstructured":"Orentreich, N., Matias, J. R., DeFelice, A. & Zimmerman, J. A. Low methionine ingestion by rats extends life span. J. Nutr. 123, 269\u2013274 (1993).","journal-title":"J. Nutr."},{"key":"77216_CR102","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1474-9726.2005.00152.x","volume":"4","author":"RA Miller","year":"2005","unstructured":"Miller, R. A. et al. Methionine-deficient diet extends mouse lifespan, slows immune and lens aging, alters glucose, T4, IGF-I and insulin levels, and increases hepatocyte MIF levels and stress resistance. Aging Cell 4, 119\u2013125 (2005).","journal-title":"Aging Cell"},{"key":"77216_CR103","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s43587-020-00006-2","volume":"1","author":"NE Richardson","year":"2021","unstructured":"Richardson, N. E. et al. Lifelong restriction of dietary branched-chain amino acids has sex-specific benefits for frailty and lifespan in mice. Nat. Aging 1, 73\u201386 (2021).","journal-title":"Nat. Aging"},{"key":"77216_CR104","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1096\/fj.201701211R","volume":"32","author":"D Yu","year":"2018","unstructured":"Yu, D. et al. Short-term methionine deprivation improves metabolic health via sexually dimorphic, mTORC1-independent mechanisms. FASEB J. 32, 3471\u20133482 (2018).","journal-title":"FASEB J."},{"key":"77216_CR105","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.cmet.2014.02.009","volume":"19","author":"SM Solon-Biet","year":"2014","unstructured":"Solon-Biet, S. M. et al. The ratio of macronutrients, not caloric intake, dictates cardiometabolic health, aging, and longevity in ad libitum-fed mice. Cell Metab. 19, 418\u2013430 (2014).","journal-title":"Cell Metab."},{"key":"77216_CR106","doi-asserted-by":"publisher","first-page":"31233","DOI":"10.18632\/oncotarget.5180","volume":"6","author":"DW Lamming","year":"2015","unstructured":"Lamming, D. W. et al. Restriction of dietary protein decreases mTORC1 in tumors and somatic tissues of a tumor-bearing mouse xenograft model. Oncotarget 6, 31233\u201331240 (2015).","journal-title":"Oncotarget"},{"key":"77216_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23782-w","volume":"12","author":"BS Choi","year":"2021","unstructured":"Choi, B. S. et al. Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice. Nat. Commun. 12, 3377 (2021).","journal-title":"Nat. Commun."},{"key":"77216_CR108","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cmet.2014.02.006","volume":"19","author":"ME Levine","year":"2014","unstructured":"Levine, M. E. et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. 19, 407\u2013417 (2014).","journal-title":"Cell Metab."},{"key":"77216_CR109","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/dvg.20271","volume":"45","author":"O Hernandez","year":"2007","unstructured":"Hernandez, O., Way, S., McKenna, J. 3rd & Gambello, M. J. Generation of a conditional disruption of the Tsc2 gene. Genesis 45, 101\u2013106 (2007).","journal-title":"Genesis"},{"key":"77216_CR110","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1074\/jbc.274.1.305","volume":"274","author":"C Postic","year":"1999","unstructured":"Postic, C. et al. Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using Cre recombinase. J. Biol. Chem. 274, 305\u2013315 (1999).","journal-title":"J. Biol. Chem."},{"key":"77216_CR111","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.44235","volume":"8","author":"MR Sullivan","year":"2019","unstructured":"Sullivan, M. R. et al. Quantification of microenvironmental metabolites in murine cancers reveals determinants of tumor nutrient availability. Elife 8, e44235 (2019).","journal-title":"Elife"},{"key":"77216_CR112","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.xphs.2020.10.037","volume":"110","author":"RJ Qasem","year":"2021","unstructured":"Qasem, R. J., Fallon, J. K., Nautiyal, M., Mosedale, M. & Smith, P. C. Differential detergent fractionation of membrane protein from small samples of hepatocytes and liver tissue for quantitative proteomic analysis of drug metabolizing enzymes and transporters. J. Pharm. Sci. 110, 87\u201396 (2021).","journal-title":"J. Pharm. Sci."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77216-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77216-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:02:36Z","timestamp":1790726556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77216-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77216"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77216-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.D.M. is a consultant for Gondola Bio, independent of the contents of this article. G.S.H. is a member of the Scientific Advisory Board and holds equity in Crescenta Pharmaceuticals (not related to the contents of this article). Additionally, technology from the Hotam\u0131\u015fl\u0131gil Lab is licensed to I\u015f Private Equity, from which G.S.H. also receives research funding. This is also not related to the contents of the article. All the other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10359"}}